Goldman Sachs Group Inc Compass Therapeutics, Inc. Put Options Transaction History
Goldman Sachs Group Inc
- $555 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CMPX
# of Institutions
80Shares Held
94.2MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA22.4MShares$22.4 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.1MShares$11.1 Million0.04% of portfolio
-
Janus Henderson Group PLC London, X06.49MShares$6.49 Million0.01% of portfolio
-
Blackstone Inc New York, NY6.19MShares$6.19 Million0.05% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$6.03 Million0.0% of portfolio
About Compass Therapeutics, Inc.
- Ticker CMPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 101,285,000
- Market Cap $101M
- Description
- Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascula...